These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1. Li Y; Wang Y; Kou L; Yin S; Chi X; Sun Y; Wu J; Jin Z; Zhou Q; Zou W; Wang T; Xia Y CNS Neurosci Ther; 2024 May; 30(5):e14738. PubMed ID: 38702933 [TBL] [Abstract][Full Text] [Related]
23. Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein-Containing Extracellular Vesicles. Hong Z; Tian C; Stewart T; Aro P; Soltys D; Bercow M; Sheng L; Borden K; Khrisat T; Pan C; Zabetian CP; Peskind ER; Quinn JF; Montine TJ; Aasly J; Shi M; Zhang J Neurology; 2021 May; 96(18):e2332-e2345. PubMed ID: 34032594 [TBL] [Abstract][Full Text] [Related]
24. Extracellular vesicles contain filamentous alpha-synuclein and facilitate the propagation of Parkinson's pathology. Ishiguro Y; Tsunemi T; Shimada T; Yoroisaka A; Ueno SI; Takeshige-Amano H; Hatano T; Inoue Y; Saiki S; Hattori N Biochem Biophys Res Commun; 2024 Apr; 703():149620. PubMed ID: 38359614 [TBL] [Abstract][Full Text] [Related]
25. Erythrocytic α-Synuclein and the Gut Microbiome: Kindling of the Gut-Brain Axis in Parkinson's Disease. Yang Y; Stewart T; Zhang C; Wang P; Xu Z; Jin J; Huang Y; Liu Z; Lan G; Liang X; Sheng L; Shi M; Cai Z; Zhang J Mov Disord; 2024 Jan; 39(1):40-52. PubMed ID: 37798868 [TBL] [Abstract][Full Text] [Related]
26. Increased Immune Activation by Pathologic α-Synuclein in Parkinson's Disease. Grozdanov V; Bousset L; Hoffmeister M; Bliederhaeuser C; Meier C; Madiona K; Pieri L; Kiechle M; McLean PJ; Kassubek J; Behrends C; Ludolph AC; Weishaupt JH; Melki R; Danzer KM Ann Neurol; 2019 Oct; 86(4):593-606. PubMed ID: 31343083 [TBL] [Abstract][Full Text] [Related]
27. miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease. Zhang J; Dongwei Zhou ; Zhang Z; Xinhui Qu ; Kunwang Bao ; Guohui Lu ; Jian Duan Biochem Biophys Res Commun; 2019 Nov; 519(4):740-746. PubMed ID: 31547989 [TBL] [Abstract][Full Text] [Related]
28. Astrocytic VEGFA: An essential mediator in blood-brain-barrier disruption in Parkinson's disease. Lan G; Wang P; Chan RB; Liu Z; Yu Z; Liu X; Yang Y; Zhang J Glia; 2022 Feb; 70(2):337-353. PubMed ID: 34713920 [TBL] [Abstract][Full Text] [Related]
29. Parkinson's Disease Derived Exosomes Aggravate Neuropathology in SNCA*A53T Mice. Huang Y; Liu Z; Li N; Tian C; Yang H; Huo Y; Li Y; Zhang J; Yu Z Ann Neurol; 2022 Aug; 92(2):230-245. PubMed ID: 35596947 [TBL] [Abstract][Full Text] [Related]
30. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Kelly LP; Carvey PM; Keshavarzian A; Shannon KM; Shaikh M; Bakay RA; Kordower JH Mov Disord; 2014 Jul; 29(8):999-1009. PubMed ID: 24898698 [TBL] [Abstract][Full Text] [Related]
31. Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease. Zhang YN; Fan JK; Gu L; Yang HM; Zhan SQ; Zhang H J Neuroinflammation; 2021 Jan; 18(1):23. PubMed ID: 33461598 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665 [TBL] [Abstract][Full Text] [Related]
33. Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease. Cardinale A; Calabrese V; de Iure A; Picconi B Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204581 [TBL] [Abstract][Full Text] [Related]
34. Extracellular microvesicles-derived from microglia treated with unaggregated α-synuclein attenuate mitochondrial fission and toxicity-induced by Parkinsonian toxin MPP Li N; Wu Y; Zhu L; Huang Y; Liu Z; Shi M; Soltys D; Zhang J; Chang Q Biochem Biophys Res Commun; 2019 Oct; 517(4):642-647. PubMed ID: 31402119 [TBL] [Abstract][Full Text] [Related]
35. α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis. Wang P; Lan G; Xu B; Yu Z; Tian C; Lei X; Meissner WG; Feng T; Yang Y; Zhang J Transl Neurodegener; 2023 Aug; 12(1):40. PubMed ID: 37620916 [TBL] [Abstract][Full Text] [Related]
36. Graphene quantum dots prevent α-synucleinopathy in Parkinson's disease. Kim D; Yoo JM; Hwang H; Lee J; Lee SH; Yun SP; Park MJ; Lee M; Choi S; Kwon SH; Lee S; Kwon SH; Kim S; Park YJ; Kinoshita M; Lee YH; Shin S; Paik SR; Lee SJ; Lee S; Hong BH; Ko HS Nat Nanotechnol; 2018 Sep; 13(9):812-818. PubMed ID: 29988049 [TBL] [Abstract][Full Text] [Related]
38. FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis. Choi YR; Kang SJ; Kim JM; Lee SJ; Jou I; Joe EH; Park SM Neurobiol Dis; 2015 Nov; 83():90-9. PubMed ID: 26342897 [TBL] [Abstract][Full Text] [Related]